IP Library Granted Patent US 11,114,184
Granted Patent B2
US 11,114,184 · App. 15/895,057 · Granted Sep 7, 2021

DNA methyltransferase 1 transition state structure and uses thereof

Inventors: Vern L. Schramm (New Rochelle, NY); Quan Du (Bronx, NY); Zhen Wang (Feicheng, CN)
Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
G16C20/50C12N9/1007C12Q1/48C12Y201/01037G16B15/00G16C20/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,114,184
App. No.
15/895,057
Granted
Sep 7, 2021
Kind
B2
Abstract

Methods and systems for obtaining inhibitors of human DNA methyltransferase 1 (DNMT1) are disclosed where the methods involve designing compounds that resemble the DNMT1 transition state.

Claims (18)

1. A method of detecting, screening for or designing an inhibitor of human DNA methyltransferase 1 (DNMT1), the method comprising the steps of:

(i) measuring kinetic isotope effects on DNMT1-catalyzed methylation of hemimethylated DNA to obtain the DNMT1 transition state structure,

wherein the DNMT1 transition state comprises the structure

(ii) determining the molecular electrostatic potential at the van der Waals surface computed from a wave function of the DNMT1 transition state and a geometric atomic volume of the DNMT1 transition state;

(iii) obtaining a chemically stable compound that resembles the molecular electrostatic potential at the van der Waals surface computed from the wave function of the DNMT1 transition state and the geometric atomic volume of the DNMT1 transition state; and

(iv) testing the compound for inhibitory activity to DNMT1 by determining if the compound inhibits DNMT1-catalyzed methylation of hemimethylated DNA;

wherein the compound that inhibits DNMT1-catalyzed methylation of hemimethylated DNA is an inhibitor of DNMT1;

thereby detecting, screening for or designing an inhibitor of human DNA methyltransferase 1 (DNMT1).

2. The method of claim 1 , wherein step (i) comprises measuring 14 C and 3 H radiation levels of mononucleosides digested from the DNA after the DNMT1-catalyzed methylation.

3. The method of claim 1 , wherein step (i) comprises measuring 14 C and 3 H labelled and unreacted SAM substrate after the DNMT1-catalyzed methylation.

4. The method of claim 1 , wherein step (i) comprises reacting 14 C—and 3 H-labeled hemimethylated DNA and nonlabeled SAM for the DNMT1-catalyzed methylation.

5. A computer-implemented method performed using a system comprising a non-transitory computer-readable medium coupled to one or more data processing apparatus having instructions stored thereon, the method comprising:

(i) determining a molecular electrostatic potential at the van der Waals surface computed from a wave function of a DNMT1 transition state and a geometric atomic volume of the DNMT1 transition state,

wherein the DNMT1 transition state comprises the structure

(ii) identifying from a library of compounds a chemically stable compound that resembles the molecular electrostatic potential at the van der Waals surface computed from the wave function of the DNMT1 transition state and the geometric atomic volume of the DNMT1 transition state;

wherein the chemically stable compound that resembles the molecular electrostatic potential at the van der Waals surface computed from the wave function of the DNMT1 transition state and the geometric atomic volume of the DNMT1 transition state is a putative inhibitor of DNMT1;

(iii) testing the putative inhibitor for inhibitory activity to DNMT1 by determining if the a putative inhibitor inhibits DNMT1-catalyzed methylation of hemimethylated DNA;

wherein the putative inhibitor that inhibits DNMT1-catalyzed methylation of hemimethylated DNA is an inhibitor of DNMT1.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2018
From: SCHRAMM, VERN L.; DU, QUAN; WANG, ZHEN
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 045002/0056 →
Continuity (2)
Provisional Application 62461268 · Feb 21, 2017
Related Publication 20180239878A1 · Aug 23, 2018